Lexicon Pharmaceuticals (LXRX) EBITDA Margin (QoQ) (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,435.00 |
| Dec 31, 2025 | -18,314.00 |
| Sep 30, 2025 | -9,888.00 |
| Jun 30, 2025 | 204,773.00 |
| Mar 31, 2025 | -191,150.00 |
| Dec 31, 2024 | 351,632.00 |
| Sep 30, 2024 | -27,870.00 |
| Jun 30, 2024 | 78,668.00 |
| Mar 31, 2024 | 195,386.00 |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | -1.54 Mn |
| Jun 30, 2020 | -25.75 Mn |
| Mar 31, 2020 | -23,953.00 |
| Dec 31, 2019 | -61,963.00 |
| Sep 30, 2019 | 223,498.00 |
| Jun 30, 2019 | -144,016.00 |
| Mar 31, 2019 | -64,379.00 |
| Dec 31, 2018 | 25,668.00 |
| Sep 30, 2018 | -10,973.00 |
| Jun 30, 2018 | -7,077.00 |